Polfa Tarchomin S.A.
Maksymilian Świniarski is a seasoned executive in the pharmaceutical and healthcare sectors, currently serving as the Chief Executive Officer and General Manager of Polfa Tarchomin S.A. since June 2024, a historic pharmaceutical company established in 1823. Prior to this role, Maksymilian held leadership positions including Co-Owner at CHC PHARMA sp. z o.o. and General Manager for Rhei Life in Poland. Maksymilian's extensive experience includes significant roles at AstraZeneca and Eli Lilly, where responsibilities encompassed managing large teams and overseeing substantial sales portfolios in the diabetes care market. Educational qualifications include a Master of Science in Political Science from Vistula University and executive training at Harvard Business School.
This person is not in any teams
Polfa Tarchomin S.A.
Polfa Tarchomin S.A. in Warsaw is one of the largest generic companies operating in Poland and one of the oldest pharmaceutical producers in the world. The company history dates back to 1823 and the production of the first medicinal preparations. Polfa Tarchomin SA is a leader in the anti-infectives market. The company also holds an significant market position in the category of insulin, psychotropic drugs and dermatological preparations. Polfa Tarchomin S.A in total provides over a hundred medicinal products. All of them are available in a range of forms and sizes in order to ensure optimal medical treatment and minimal side effects experienced by the patient. Polfa Tarchomin S.A. specialises in the prescription drugs. Over the counter medicines constitute a supplement to the main product range. Our medicines are produced in buildings and facilities which meet strict global requirements and quality standards. The quality of our products has been confirmed by the obtained GMP certificates. Currently the company has 40 production lines and installations which produce drugs in pharmaceutical forms including gels, aerosols, tablets, coated tablets, capsules, ampoules, vials and insulin cartridges. The production line of oral penicillin forms, aerosol filling and freeze-drying techniques distinguish the company among other manufacturers in the industry.